参考文献/References:
[1] LIU Q Q,CHEN K,YE Q,et al.Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway[J].Cancer Cell Int,2016,16(1):57.
[2] 朱鑫哲,李浩,徐华祥,等.2021年胰腺癌研究及诊疗新进展[J].中国癌症杂志,2022,32(1):1-12.
ZHU X Z,LI H,XU H X,et al.Advances in basic research,clinical diagnosis and treatment of pancreatic cancer in 2021[J].Chin Oncol,2022,32(1):1-12.
[3] TRAUB B,LINK K H,KORNMANN M.Curing pancreatic cancer[J].Semin Cancer Biol,2021,76:232-246.
[4] 冉倩,徐进宜,吴晓明,等.冬凌草甲素的研究进展[J].药学与临床研究,2007,15(2):91-95.
RAN Q,XU J Y,WU X M,et al.Advances in the research of oridonin[J].Pharm Clin Res,2007,15(2):91-95.
[5] QING K,JIN Z,FU W,et al.Synergistic effect of oridonin and a PI3K/mTOR inhibitor on the non-germinal center B cell-like subtype of diffuse large B cell lymphoma[J].J Hematol Oncol,2016,9(1):72.
[6] BU H Q,LIU D L,WEI W T,et al.Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK[J].Oncol Rep,2014,31(2):975-982.
[7] SHI X J,DING L,ZHOU W,et al.Pro-apoptotic effects of JDA-202,a novel natural diterpenoid,on esophageal cancer through targeting peroxiredoxin I[J].Antioxid Redox Signal,2017,27(2):73-92.
[8] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.
[9] GBD 2019 DISEASES AND INJURIES COLLABORATORS.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[10] 谢涛,杨正强,徐文武,等.冬凌草化学成分,药理作用及临床应用研究进展[J].中草药,2022,53(1):317-325.
XIE T,YANG Z Q,XU W W,et al.Research progress on chemical constituents,pharmacological effects and clinical application of Rabdosia rubescens[J].Chin Trad Herbal Drugs,2022,53(1):317-325.
[11] ZHOU C,ZHANG J Y,LIU H B.Synthesis,biological evaluation and cellular localization study of fluorescent derivatives of Jiyuan Oridonin A[J].Eur J Med Chem,2022,229:114048.
[12] KE Y,HU T X,HUO J F,et al.Synthesis and in vitro biological evaluation of novel derivatives of Flexicaulin A condensation with amino acid trifluoroacetate[J].Eur J Med Chem,2019,182:111645.
[13] LIU Y,SONG Z,LIU Y,et al.Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer[J].Acta Pharm Sin B,2021,11(6):1513-1525.
[14] VADIVEL GNANASUNDRAM S,BONCZEK O,WANG L,et al.p53 mRNA metabolism links with the DNA damage response[J].Genes (Basel),2021,12(9):1446.
[15] FOSTER E R,DOWNS J A.Histone H2A phosphorylation in DNA double-strand break repair[J].FEBS J,2005,272(13):3231-3240.
[16] SHI T,VAN SOEST D M K,POLDERMAN P E,et al.DNA damage and oxidant stress activate p53 through differential upstream signaling pathways[J].Free Radic Biol Med,2021,172:298-311.
[17] ZHANG C,LIU J,WANG J,et al.The interplay between tumor suppressor p53 and hypoxia signaling pathways in cancer[J].Front Cell Dev Biol,2021,9:648808.
[18] 朱晗清,高丰厚.冬凌草甲素上调p53转录活性促进胶质瘤细胞凋亡的作用与分子机制探讨[J].现代肿瘤医学,2019,27(7):1140-1144.
ZHU H Q,GAO F H.Oridonin up-regulated p53 transcriptional activity promoted apoptosis of glioma cells and its molecular mechanism[J].J Mod Oncol,2019,27(7):1140-1144.
[19] 马妍,刘荣兴,朱茄慧,等.冬凌草甲素抑制SW620结肠癌细胞增殖与BMP7-p53通路的相关性研究[J].药物评价研究,2018,41(10):1770-1774.
MA Y,LIU R X,ZHU Q H,et al.Relationship between anti-proliferation effect of Oridonin on SW620 cells and BMP7-p53 pathway[J].Drug Eval Res,2018,41(10):1770-1774.